Merit Medical Systems recalled 447 units of the 10Fore Hemostasis Valve on July 25, 2025. A manufacturing issue may cause a deformed silicone quad ring, posing a risk of foreign body in the fluid pathway. This recall affects the U.S. and Canada.
Due to a manufacturing issue involving the silicone quad ring where the ring is deformed or otherwise damaged and may cause a foreign body in the fluid pathway.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Merit Medical Systems, Inc. or your healthcare provider for instructions. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
The recalled 10Fore Hemostasis Valve includes Catalog Numbers MAPTEN4, MAPTEN42, and MAPTEN452. The affected lot numbers are H3098831, H3111155, H3152503, H3155611, H3186901, H3076189, H3111156, H3152504, H3155614, H3173674, and H3111162. The product was distributed worldwide, including states such as California, Florida, Louisiana, Montana, New York, South Dakota, and Wisconsin.
The recall stems from a manufacturing defect in the silicone quad ring, which can become deformed or damaged. This poses a high risk as it may lead to a foreign body in the fluid pathway.
No specific incidents or injuries have been reported related to this recall yet. However, the potential for a foreign body in the fluid pathway is significant.
Patients and healthcare providers should stop using the 10Fore Hemostasis Valve immediately. Follow the recall instructions provided by Merit Medical Systems, Inc. Contact them for further guidance.
For more information, contact Merit Medical Systems, Inc. or visit the FDA recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=Z-2553-2025.
Get instant alerts for recalls that affect you. Free forever.
Glenmark Pharmaceuticals recalled nearly 97,000 packs of Ondansetron Orally Disintegrating Tablets on December 30, 2025. Defective blister packs may not fully seal, leading to tablets falling out. Consumers should stop using the product immediately and contact healthcare providers.
Novo Nordisk recalled Wegovy (semaglutide) injections on December 19, 2025, after discovering hair in prefilled syringes. The contamination poses a serious hazard to consumers. The recall affects all units distributed nationwide.
Novo Nordisk recalled Wegovy (semaglutide) Injection on December 19, 2025, due to hair found in a prefilled syringe. The recall affects products distributed nationwide in the United States. Consumers should stop using the product immediately and contact their healthcare provider.
Zydus Pharmaceuticals recalled over 2,100 bottles of TraZODONE Hydrochloride Tablets on December 19, 2025. Some tablets have surface dents that may affect medication integrity. Consumers should stop using the product immediately and seek guidance from healthcare providers.
CareFusion 213, LLC recalled 106,400 units of ChloraPrep Triple Swabsticks on December 17, 2025. The recall occurred due to a lack of assurance of sterility. Consumers must stop using the product immediately and contact CareFusion for guidance.
Merck Sharp & Dohme LLC recalled 845 kits of Noxafil Powdermix on December 12, 2025. The recall follows the discovery of potential metal particulates in the product. Consumers should stop using the medication immediately and contact their healthcare provider for further guidance.
Merck Sharp & Dohme LLC recalled 3 single-dose kits of Emend (aprepitant) on December 12, 2025. The recall stems from the potential presence of metal particulates in the medication. Consumers should immediately stop using the product and contact their healthcare provider for guidance.
Beaver-Visitec International recalled five units of the OME6000U Laser and Endoscopy System on December 5, 2025. The recall stems from a manufacturing deviation where ferrites required for the USB cable were not installed. This omission poses a high electrical hazard risk to patients and healthcare providers.